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Isoantigenic differences  in immunoglobulins  have been demonstrated in man  (Gin 
and Inv groups)  (1-3), and rabbit (allotypes) (4). Recent studies in the mouse have 
described a similar polymorphism for immunoglobulin  isoantigens (5-8), one of which 
occurs in a  subclass of  7S gamma globulins, ~'2, (9),  and the  other  in ~A  (/32A)-im- 
munoglobulins (10).  These antigens, which have been localized  to  the  F  fragments 
after papain digestion (11),  and are therefore on the H  (A) chain, are controlled by 
closely  linked genetic loci  (10).  In this publication we will be concerned only with 
the locus which  controls the  isoantigens on  7S  (T2,)-globulins.  Four alleles  at  this 
locus have previously been described (10). 
In order to further investigate the genetic control of these antigens, a  highly 
sensitive immunochemical method was  developed, based on the  inhibition of 
precipitation of  labeled ~,-globulin (12).  With  this  test  the  degrees  of  cross- 
reactivity of antigens of  the  individual strains could be readily detected,  en- 
abling the identification of eight distinct types. 
The notation for  the locus and its phenotypes used in this paper has previously 
been described (10) and follows the recommendations resulting from a discussion be- 
tween members of the committee on Standardized Genetic Nomenclature For Mice 
(13) and some of those workers who have published on immunoglobulin isoantigens 
of  mice.  The  locus discussed  in this  paper  is  designated Ig-1  (Immunoglobulin-1) 
and eight alleles are  described.  The individual antigenic specificities  determined by 
each of the alleles are defined  and designated by a method analogous to that used to 
describe cross-reacting antigens in the Rh and H-2 blood group systems (14-16). 
Materials  and  Methods 
M/ce.--Young adult mice of both sexes were obtained from inbred colonies maintained in 
various laboratories, as indicated by the substrain symbols (17). We are indebted to Dr. L. 
Russell, of Oak Ridge National Laboratories, and to the staff of the Roscoe B. Jackson Labora- 
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GM-12075, CA-04681, and Training Grant 2TI-GM295. 
:~ Fellow of the Helen Hay Whitney Foundation. 
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tories, Bar  Harbor,  notably  Dr.  M.  Green,  for providing most  of the mice used in  linkage 
studies. The strains used, together with their substrain designation, are listed in Table X. In 
this paper the following abbreviations kave been used : AKR/J, AKR; C3H/HeJ and C3H/Hz, 
C3H; C57BL/6J and C57BL/10Hz, C57BL; DBA/2J, DBA. 
Gamma Globulin Isolation.--Samples of pooled normal whole serum were concentrated 3 to 
4-fold by pressure dialysis and  then  subjected to  electrophoresis in  1 per  cent  Ionagar  in 
veronal buffer pH 8.2,  on glass plates, using a  wide central trough for 4 hours at 30 ma and 
5 to 6 v/em. Serial ~  centimeter strips were then cut perpendicular to the direction of the cur- 
rent flow from the cathodal end of the slide to the origin.  Protein was eluted from the agar 
strips by soaking in phosphate-buffered saline (0.01 i  phosphate, 0.85 per cent NaCl, pH 7.1) 
for 48 hours, followed by reconcentration by pressure dialysis. Samples of each fraction were 
individually tested for the presence of gamma globulin and other serum proteins by imrnuno- 
electrophoresis with a  rabbit  anti-mouse whole serum. Only the  most cathodal  fractions of 
gamma globulin were used for 1125 labeling. A  typical immunoelectrophoretic pattern of such 
a  fraction is shown in Fig.  1. 
FIG.  1. Immunoelectrophoresis of a gamma globulin preparation from DBA/2  serum used 
for 112a labeling, compared to whole DBA/2 serum. The central trough contained a polyvalent 
rabbit anti-whole mouse serum. 
Iodination with I125.--Iodination of approximately 100/zg portions of gamma globulin was 
performed by the method of Greenwood et al.  (18)  with an average labeling of 1 atom 1125 per 
molecule. Passage through anion exchange resin columns followed by dialysis against saline 
was  used  to  remove unbound iodide. Approximately 20 per cent of the added iodide became 
attached to the protein. 
Precipitation of [odinated Gamma Globulin.--All reactions employing labeled gamma globu- 
lin were carried out in 6 x 50 mm culture tubes. Labeled antigens were diluted in a 3 per cent 
bovine serum albumin (BSA) (Armour Pharmaceutical Company, Kankakee, Illinois) solution 
in 0.05  M tris buffer (final pH  7.6).  All antisera used were diluted in serum diluent  (S-dil): 
0.05 i  tris, containing 3 per cent BSA and  10 per cent normal rabbit serum,  pH adjusted to 
7.6. 
For the reaction, 50/zl of diluted labeled antigen was added to 50 #1 of varying dilutions of 
the antisera. The tubes were left at 37°C for 3 hours, chilled to 4°C and then spun cold at 10,000 
g for 10 minutes; 50 #1 of the supernatant was carefully removed and placed in a  10 x 75 mm 
disposable tube containing approximately 0.5 ml of normal saline. These were then counted in 
a well type crystal gamma scintillation counter. 
The maximum percentages of precipitation of the five labeled antigen preparations used for 
these studies by rabbit antisera, mouse isoantisera and trichloracetic acid (TCA) are shown in 
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Isoimmunization.--A  basic  schedule  of  immunization was  followed  for  preparing  the 
majority of antisera used in this study. Minor changes in antigen dosage and timing have been 
made occasionally with little apparent  affect. A primary subcutaneous injection of 10 #1 of 
T~LEI 
Pr~ipitation~I-m~bd~mma~o~i~ 
Antiserum 
Trichloracetic  acid* 
Rabbit anti-whole mouse serum§ 
Rabbit anti-mouse 7S  "/'1 +  7S  ~/211 
Rabbit anti-mouse 7S 7~I] 
Specific  mouse isoantiserum¶ 
Rabbit anti-mouse "YIA (asA)][ 
Mouse anti-complement (HO)* * 
IlS~-labeled gamma globulin  preparation 
C3H 
99~ 
96 
95 
89 
76 
5 
0 
C57BL 
98 
88 
79 
67 
55 
2 
0 
DBA/2 
99 
83 
75 
64 
55 
0 
0 
AKR 
99 
90 
87 
82 
72 
0 
0 
A/J 
94 
70 
69 
60 
61 
2 
0 
* Final concentration of 7.5 per cent, reaction at 4°C. 
~t Numbers in table give the maximum per cent of I m  radioactivity 
§ Polyvalent antiserum as used in Fig. 1. 
I[ Kindly provided by Dr. J. Fahey (27). 
¶  Each antigen was precipitated by its homologous isoantiserum. 
** A DBA/2 anti-C3H anti-HO serum (19). 
precipitated. 
TABLE II 
Comparison of Immunogenicity  oJ Gamma Globulin of Normal and Immune Sera 
Donor strain 
C57BL 
o: 
NZB 
~c 
Type  of donor  serum 
Normal 
Anti-DBA/2 spleen  ~ 
Normal 
Anti-HO§ 
Recipient strain 
BALB/C 
BALB/C and C57BL 
No. of mice 
Sltive/total 
• of mice* 
0/10 
48/48 
0/12 
8/9 
* Number of mice producing anti-gamma globulin isoantibodies as detected by precipita- 
tion of I125-1abeled antigen/total number of mice injected. 
Antiserum prepared by immunizing C57BL mice with  DBA/2  spleen  cells  (BALB/C 
and DBA/2 have the same H-2 allele). 
§ Anti Hc  1 (a/~-globulin component of complement) prepared by immunizing NZB mice 
with whole BALB/C serum. 
whole serum per mouse in complete Freund's adjuvant was followed 3 weeks later by two 
weekly intraperitoneal injections each of 10 #1. The mice were bled 1 week later and individual 
sera tested for the presence of isoantibodies. Mice failing to produce detectable antibodies were 
then alternately injected and bled at weekly intervals for about 1 month, and then discarded if 
still negative• 
Although normal serum may be used as antigen,  far better results have been obtained by 418  MOUSE  IMMUNOGLOBULIN  ISOANTIGENS.  I 
using as the antigen, serum from animals which contain antibodies directed to some tissue or 
protein component in the recipient strain. Two such examples of this are given in Table II. 
Whereas BALB/c mice immunized with normal (C57BL) serum failed to produce any detect- 
able isoantibodies to C57BL gamma globulin, immunization of the same strain with a C57BL 
anti-DBA/2 spleen antiserum was quite successful (BALB/c and DBA/2 have the same H-2 
antigen). Similarly, an antiserum to a  complement component antigen, (He  1)  (19), was also 
effective as an antigenic serum. 
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~1.  OF ANTISERUM 
l~Ie. 2, Precipitation of It~5-1abeled C3H gamma globulin (0.0l/zg) by two isoantisera.  O 
C57BL anti-C3H; Q  RIII anti-129. Total volume 0.1 ml. 
Testing o.f Ant#era.-- 
(a) Precipitation in agar: Individual samples of sera from immunized animals were tested 
for precipitation by the Ouchterlony technique (20) on microscope slides with normal sera of 
several strains and also with purified serum proteins. Those sera showing identical patterns of 
reactivity (and prepared in identical fashion), were then pooled. Immunoelectrophoresis (21) 
was used to determine the specificity of the antisera when several lines were observed in double 
diffusion with normal serum. Most of the precipitating isoantisera obtained react with immuno- 
globulins. Some were found that precipitated with other serum proteins as reported elsewhere 
(19, 22). Both Ouchterlony and immunoelectrophoretic tests were carried out in 0.05 ~ barbital 
buffer in I per cent Ionagar at pH 8.2. 
(b) Prec@ital~on of labeled antigens:  Antisera from immunized mice were tested for ability 
to precipitate labeled gamma globulin of the immunizing strain type. These tests were per- 
formed as described above using approximately 0.01/zg labeled antigen per tube. This test 
was found to be consistently far more sensitive than direct precipitation in agar. Many sera L.  A.  HERZENB]~RG~ N.  L.  WARNER~ L. A.  BERZENBERG  419 
were found that did not show any precipitation in agar, but precipitated the labeled antigen 
even with antiserum dilutions of 1/1000. 
Inkibition of Pre~ipitalion of lsoant~gens.--An  adaptation of a method of estimating gamma 
globulins (12) based on the inhibition of precipitation of labeled reference antigens was em- 
ployed. Concentrations of labeled antigen and antisera were chosen as follows: A standard 
concentration of labeled gamma globulin, giving about  10,000 counts per minute per 50 #1 
was chosen, and precipitated,  as described above, with setial dilutions of isoantiserum. An 
amount of antiserum slightly below equivalence was then determined (i.e., an amount which 
precipitates 80 to 90 per cent of the precipitable counts).  A  typical  titration is shown in 
Fig. 2, in which two different antiscra to C3H gamma globulin were titrated against a con- 
stant amount of labeled C3H gamma globulin. 
The inhibition assay was performed in a fashion similar to the precipitation of labeled anti- 
gens. The order of addition of the reagents is quite critical. Fifty/zl of a dilution of labeled anti- 
gen was placed in all tubes, followed by the addition of 5 ~1 of serial dilutions (in S-dil) of test 
(inhibitor) whole sera. At the addition of 50/~1 of diluted isoantiserum each tube was immedi- 
ately mixed on a vortex Jr. mixer (Scientific Industries, Springfield,  Massachusetts).  Two con- 
trois were included in each assay. One tube contained 55 #1 of the diluent (S-dr)  with 50/~I 
of labeled antigen and was the control of total radioactivity (i.e., no'precipitation and referred 
to as T). The other control tube determined maximum precipitation (i.e. no inhibition) and 
contained 50 #1 of antiserum,  5 #1 of S-dil, with 50 #1 of labeled antigen (referred to as A). 
Incubation, centrifugation, and sampling were carried out as described above. 
Determination  of Cross-Reaction.--The  usual  methods  of determining the presence of a 
cross-reaction  in  precipitating  antigen-antibody  systems,  (spur  formation  in  Ouchtetiony 
and precipitin formation) are not sufficiently sensitive to detect many of the cross-reactions 
found in this study, particularly as some of our antisera do not even visibly precipitate in 
agar. A more sensitive method of determining cross-reactivity was therefore sought. 
Determination  of percentage cross-reaction (CR): The CR value is a measure of the ability 
of a test serum, present in excess, to inhibit labeled antigen precipitation. To determine this 
value, the inhibition assay was set up with a test serum using 5/A of a  1/10 dilution which 
previous tests have shown to contain an excess of the unlabeled antigen. The CR is calculated 
from the following formula, all values used being the counts per minute of 50 #1 of the super- 
natant. 
1-A 
Cg(per cent) =  --  X  100 
T--A 
where I is the count in the tube containing labeled antigen, antisera, and inhibitor (test serum); 
A  is  the  count  in  the  tube  containing labeled  antigen  and antiserum;  T  is the  count  in 
the tube  containing labeled  antigen  and  S-dil; and  T  -- A  is  the number of counts pre- 
cipitated. When inhibition of precipitation of the labeled antigen is complete, [  -- T and CR 
--- 100. When there is no inhibition of precipitation, I  -- A and CR =  O. 
RESULTS 
Ouchterlony  Tests with Isoantisera.--Five  types  of antisera produced by  the 
methods  described  have  been  tested  against  normal  whole  sera  from  a  large 
number  of strains.  Each antiserum  reacted with its corresponding  immunizing 
serum to form a  single line of precipitation  in Ouchterlony slides and  a  single 
arc  of  precipitation  in  immunoelectrophoresis  corresponding  to  the  gamma 
globulin arc seen with polyvalent rabbit anti-mouse whole sera.  Previous stud- TABLE  III 
Precipitation of Normal Mouse Sera in Agar by Isoantibodies 
Antigen strain 
A/J .................... 
AKR/J ................. 
AL/N .................. 
B10.D2/Hz .............. 
BALB/cCrglGa ......... 
BDP/J ................. 
BRSUNT/N ............ 
BSL/Di ................. 
BUB/Bn ................ 
C3H/Hz ................ 
C3H.SW/Hz ............. 
C57BL/Ka .............. 
C57BL/6J .............. 
C57BL/10Sn ............ 
C57BR/CdJ ............. 
C57L/J ................. 
CS8/J .................. 
CBA/J .................. 
CE/J  ................... 
DA/Hu ................. 
DBA/1J ................ 
DBA/2J ................ 
DD/He  ................. 
DE/J ................... 
FZ/Di .................. 
HG/Hu ................. 
JB/Di .................. 
LP/J ................... 
MA/J  .................. 
MA/MyJ ............... 
P/J ..................... 
PL/J ................... 
RIII/J .................. 
RF/J ................... 
SEA/Gn ................ 
SEC/Gn ................ 
SJL/J .................. 
SM/J ................... 
ST/J ................... 
STR/N .................. 
SWR/J  .................. 
W-B/Re .................. 
WC/Re ................. 
WH/Re  ................. 
WK/Re  .................. 
58/N  .................... 
101/R1 .................. 
129/RrGa ................ 
Antlsers 
C57BL anti- 
C3H (serum 
pool G--IL) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
C57BL anti- 
C3H (serum 
pool G--1P) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
nt 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
C31t anti- 
C57BL 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
C57BL anti- 
DBA/2 
m 
m 
nt 
+ 
+ 
+ 
+ 
+ 
nt 
+ 
+ 
nt 
+ 
C57BL anti- 
AKR 
+ 
+ 
+ 
nt 
nt 
+, positive reaction in agar gel diffusion with specified antiserum. 
--, negative reaction. 
nt, not tested. 
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ies have described in more detail the molecular class bearing the isoantigen to 
be 7S 7~  (9). The reactions of these five antisera with 48 normal sera are given 
in Table III.  Although two of the antisera were made with the same donor- 
recipient combination, each of the five has a  different reaction pattern.  The 
only difference between the two C57BL anti-C3H antisera is that serum pool 
G-1P reacts with some strains with which the serum pool G-1L does not. This 
group of strains is also the only one positive with the C57BL anti-DBA/2 anti- 
sara. 
From the data in Table III, four groups of strains each with a unique pattern 
of reactions may be recognized. Evidence that  the antigens  carried by these 
strains are controlled by four alleles at a single locus is presented in the follow- 
ing section. The reactions of a reference (or type) strain for each group (allele) 
is listed in Table IV. Since two of the antisera react with strains in more than 
TABLE IV 
Precipitation of Reference Strain Sera in Agar by Isoantisera 
Allele 
Ig-1 • 
Ig-1 b 
Ig-1 c 
Ig-1  d 
Type strain 
C3H/HeJ 
C57BL/10J 
DBA/2J 
AXR/J 
C57BL anti- 
CJH (G-IL) 
+ 
+ 
Antlsera 
C3H  C57BL anti-  anti- 
CJH (G--IP)  [  C57BL 
I 
+ 
-  + 
+ 
+ 
C~TBL 
anti- 
DBA/2 
+ 
C57BL 
anti- 
AKR 
+ 
one of the four antigen groups, it is evident that some of the alleles must de- 
termine several antigenic specificities. Further definition of antigenic specifici- 
ties is made in a later section. 
Allelism.--The  results of testing reciprocal backcross and  F2  progeny be- 
tween C57BL and C3H with a  C57BL anti-C3H gamma globulin and a  C3H 
anti-C57BL  gamma globulin antiserum  (Table V, lines  1 to 3)  indicate that 
these two antigens, Ig-la and Ig-lb, are specified by genes at a single locus (or 
chromosome region), which has been named Ig-1 (Immunoglobulin-1) (10). The 
last two lines of Table V present the results of test crosses which show that 
Ig-1 a and Ig-1 c, and Ig-1 ~ and Ig-1 d are alleles. From these results, it must  be 
concluded that all four antigens are determined at the same genetic locus and 
that there are four alleles. 
Further subdivision of these four groups of strains was then attempted (a) 
by the production of different antisera and  (b) by determining the degree of 
cross-reaction of normal sera from different strains in inhibition assays with 
different antigen-antibody systems. 
Precipitation  of la25-Labeled  Gamma  Globulin  by Isoantisera.--Antisera  were TABLE V 
Segregation ~  GenesDet~miningGammaGlob~inlsoantigens(lO) 
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prepared by immunization between mice with different Ig-1 alleles and with 
the same apparent allele as indicated by the patterns of reactivity in Table III. 
The ability of 10 of these antisera to precipitate labeled gamma globulin from 
five strains are listed in Table VI. Data from this table is used in a later section 
in determining antigenic specificities. 
Cross  Progeny 
Parent strains  Parent I g-1 
genotypes 
C3H x C57BL)F1 x 
C57BL 
C3H x C57BL)F1 x C3H 
C3Hx C57BL)F1 ® 
',C3H x DBA/2)F1 x 
B10.D2 
AKR x DBA/2)F1 x 
C57BL 
Progeny 
Ig-1 geno- 
type 
a/b x b/b 
a/b x a/a 
a/b x a/b 
a/c x b/b 
d/c x b/b 
Tested with  Result  Total  tested 
Anti-Ig-la*  +51 
--39 
9O 
+233 
--209 
442 
] 
(a)  Anti-Ig-lb  +202§ 
(b)  Anti-Ig-lb  ;}7811 
Anti-Ig-la 
28O 
(a)  nnti-Ig-la  +} 
Anti-Ig-lc¶  78 
(b)  Anti-Ig-la  ;}71 
Anti-Ig-lc 
149 
(a)  Anti-Ig-lc  +}71 
Anti-Ig-ld**  -- 
(b)  Anti-Ig-ld  +}82 
Anti-Ig-lc 
a/b 
b/b 
422 
Anti-Ig-lb~  b/a 
a/a 
153 
b/a-I- 
b/b 
a/a 
a/b 
i  L  q 
I 
I  c/b 
I 
t 
c/b 
I 
L 
d/d 
* Anti-Ig-la, C57BL anti-C3H. 
Anti-Ig-lb, BALB/C anti-C57BL. 
§ Not tested for segregation  of Ig-la. 
i[ Sera from only 51 of the 78 Ig-lb negative animals were available for testing with anti- 
Ig-la. All were Ig-la positive. 
¶  Anti-Ig-lc, C57BL  anti-DBA/2. 
** Anti-Ig-ld, DBA/2 anti-AKR. L. A. HERZENBERG,  N. L. WARNER,  L. A. HERZENBERG  423 
Labeled C3H  gamma globulin has been shown  to be precipitated by many 
antisera produced in mice  immunized with  sera from strains  apparently dif- 
ferent from C3H.  The actual percentage of C3H gamma globulin precipitated 
TABLE VI 
Precipitation of II~5-Label~ Gamma Globulins by Mouse Isoantisera 
Ant~era 
C57BL anti-C3H 
BALB/C anti-C57BL 
C57BL anti-DBA/2 
DBA/2 anti-AKR 
C57BL anti-AKR 
BALB/C anti-NZB 
C57BL anti-A/J 
RIII anti-129 
RIII anti-C57BL 
CE anti-129 
II~-labeled  gamma  globulin 
C3H 
p* 
N 
P 
P 
P 
N 
P 
P 
N 
P 
C57BL 
N~ 
P 
N 
N 
N 
N 
N 
N 
P 
P 
DBA/2 
P 
N 
P 
N 
N 
N 
P 
N 
N 
P 
AKR 
P 
N 
P 
P 
P 
P 
P 
P 
N 
P 
b/I 
P 
N 
P 
P 
P 
P 
P 
P 
N 
P 
* Percentage of precipitation shown in Table I. 
:~ Less than 5 per cent precipitation. 
TABLE VII 
Precipitation of Im-Labeled Antigen by Homologous and Cross-Reacting Antisera 
Type 
Ant~erum 
Ig-1  b (C57BL) anti-Ig-1  * (C3H) 
Ig-1  b (C57BL) anti-lg-1  ¢ (DBA/2) 
ul Added 
Both together 
2+2 
Per cent of Ira-labeled 
C3H/HeJ (Ig-I  a) gamma 
globulin  precipitated 
75 
74 
75 
71 
72 
72 
Each tube contains 0.04 pg I~-labeled C3H gamma globulin and the indicated antiserum 
volume. Total volume per tube was 0.! ml. 
by antisera to two  (C3H and DBA/2) of the four reference strains previously 
established is shown in Table VII. Since both of the antisera and a  mixture of 
them, precipitate the same amount of labeled C3H antigen, each C3H molecule 
must have at least one antigenic specificity shared by DBA/2. However, these 
results do not preclude the possibility  that different 7S 3,-globulin molecules in a 424  MOUSE IMMUNOGLOBULIN ISOANTIGENS. I 
serum may be carrying other antigenic specificities  not detected with the anti- 
sera used in table VII. 
Sensitivity of Assay.--Before describing the actual results used in the further 
elucidation of antigenic specificities,  the data from a few inhibition assays will 
be given in order to demonstrate the ability of this technique to detect partial 
cross-reactions and also to indicate the sensitivity of the method for detecting 
gamma globulin. The results presented in Fig. 3 were obtained from four in- 
C3H  x -- I  Iz5 
C57BL  ANTI-C3H 
C57BL 
DBA/2 
0~0~ 
~_  I|  b  o  ...... 
rot/\  ~0 
"O~AKR 
C3H  o 
o  o 
i  I  1  I  I  I  I  I  I  , 
2  4  8  16  250  500 
p.I x  I0  "z  OF  INHIBITOR  SERUM 
IIG. 3. Inhibition of precipitation  of II~-labeled C3H gamma globulin by normal sera. Each 
tube contains 0.02/zg of labeled antigen and 0.25 #1  of a C57BL anti-C3H isoantisemm in a 
total volume of 0.1 ml. The volumes of inhibitor serum added to each tube are shown on the 
abscissa. The scale is broken at the double vertical line. 
hibition assays performed in  the  manner  described  in  the  methods section, 
using C3H-labeled antigen, a C57BL anti-C3H antiserum, and serial dilutions 
of four test sera, namely C3H, AKR, DBA/2,  and  C57BL. The results  are 
plotted in Fig. 3 as the percent of radioactivity precipitated against the amount 
of inhibitor serum.  C3H  serum shows  detectable  inhibition of precipitation 
with  0.01  /zl  and  complete  inhibition is  achieved with  approximately 0.02 
/zl of whole serum. DBA/2 and AKR sera also show detectable inhibition with 
0.01  /zl of whole serum. However, complete inhibition is not achieved with up 
to 1.0 Izl of DBA/2 and AKR sera, inferring that DBA/2  and AKR sera  do 
not contain all the specificities on the reference (C3H)-labeled antigen to which 
antibodies are present. The greater degree of inhibition by AKR than DBA/2 L.  A.  HEP,  ZENBERG,  N.  L.  WARNER,  L.  A.  HE.RZENBERG  425 
could be interpreted to indicate a  greater similarity d  AKR with C3H than 
DBA/2 with C3H (see Discussion). 
Further  inhibition  was  encountered with  high  concentrations of DBA/2, 
AKR, and normal C57BL serum (the strain in which the antibodies were made). 
The amount of serum required to cause this inhibition was about 100 to 1000- 
fold greater than that producing specific inhibition. This could be due to either 
very small amounts of C3H type gamma globulin specificities in the DBA/2, 
AKR,  or  C57BL serum  causing  inhibition by specifically competing for the 
antibody,  or  to  the  ability of high  serum  concentrations  to non-specifically 
inhibit precipitation. Since this type of inhibition was not encountered with 
the concentrations of inhibitor sera used in the following sections, it does not 
TABLE  VIII 
Antigenic Spedf~ities  Present in Ig-1 Atldes 
AUele  Type strain 
Ig-1 •  C3H/HeJ 
Ig-1 b  C57BL/10J 
Ig-1 o  DBA/2J 
Ig-1 a  AKR/J 
Ig-1 e  A/J 
Ig-l~  CE/J 
Ig-lg  RIII/J 
Ig-1 h  SEA/Gn 
Antigenic spedfidties 
1  2  3  4  1  5  1  6  ,  8 
2  a  7  § 
1  2  5  7  ND 
1  2  6  7  8 
1  2  -  ND 
2  ND 
1  2  6  7 
* Number means specificity is present. 
~; Dash means specificity is absent. 
§ Not done. 
affect the conclusions to be made. However, further investigation is proceeding 
to determine the nature of this inhibition. 
Detection of More Alleles and Antigenic  Specificities.--At  the present stage 
of this work, it is probable that as new antisera are produced further antigenic 
specific§ties  will  become apparent.  However, sufficient data  are  available  to 
commence to identify antigenic specific§ties  for a number of alleles. The anti- 
genic specific§ties  defined by the  available  antisera for selected type strains 
are given in Table VIII. To assist in the interpretation of the data which was 
used to compile this chart, Table IX lists the antigenic specific§ties recognized 
by the antisera used in these tests. These in turn, were reasoned from the known 
reactions and cross-reactions of the various antisera and use the numbers for 
specific§ties listed in Table VIII. 
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two strains does not of necessity yield antisera detectably reacting to the same 
determinants.  In fact, such antisera have often been found to have different 
ratios of antibodies to the different specificities. 
The absolute values of CR (cross-reactions, see Materials and Methods) de- 
pend on the particular pool of antiserum used as well as on its concentration, so 
while CR values in a given experiment are directly comparable, those in dif- 
ferent sections are not. In all inhibition assays performed, complete inhibition 
was always obtained with sera of the immunizing strain and with sera from the 
same strain as that of the labeled gamma globulin used in the assay. 
In the analysis of the antigenic specificities from the following data, several 
rules have been followed. 
(a) A strain producing an isoantiserum has none of the specificities recognized 
by that antiserum. 
TABLE  IX 
Antigenic Spevificities Daected by Isoanlisera in Various Labeled Gamma Globulin Preparations 
Antiserum  Labeled gamma globulin  Antigenic specificities 
detectable 
C57BL anti-C3H 
C57BL anti-DBA/2 
BALB/C anti-C57BL 
BALB/C anti-NZB 
CE anti-129 
C3H 
DBA/2 
AKR 
n/J 
DBA/2 
C57BL 
A/J 
C3H 
C57BL 
1, 2, 6, 8 
2 
i, 2 
1, 2, 6, 8 
2, 3 
4 
5 
6, 7 
7 
(b) The immunizing strain has all the specificities recognized by the antiserum 
regardless of the type of antigen used to detect the  antibodies present in the 
antiserum. 
(c) However, the specificities detected in the immunizing strain by an antise- 
rum made against it are not necessarily all of the antigenic specificities present in 
the immunizing strain (i.e., antibodies may not be present to all the specificities). 
(d)  The specificities detected by an  antiserum  when used with  a  labeled 
antigen from a strain other than the immunizing strain, represent the specifici- 
ties detected by the antiserum minus  those specificities which are present in 
the immunizing strain and absent in the labeled antigen. 
(e) A test serum which completely inhibits has all the specificities detected 
by the antiserum in that assay, while a test serum which does not inhibit at all 
has none. 
(f) A test serum which partially inhibits a reaction has some but not all of the 
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(g)  Two strains  which each partially inhibit  in a  given reaction,  need not 
share any specificities with each other, but each shares some specificities with 
the labeled antigen strain and the immunizing  strain. 
(h) The number of specificities is always a minimum estimation of the number 
compatible with the results. 
The following notation is used: 
An I~5-1abeled preparation of gamma globulin  is indicated with an  asterisk 
following  the symbol of the strain from which it was prepared,  (for example, 
C3H*), while  normal  sera used in inhibition  assays are listed by the strain 
symbols (e.g.,  C3H). The symbols C3H*-C57BL anti-C3H refer to the use of 
a labeled C3H gamma globulin preparation with a C57BL anti-C3H antiserum 
in an inhibition assay. The statement,  "(C3H 1)" means C3H has specificity 
one.  The statement,  "(C57BL  --1)" means C57BL does not have specificity 
one. The terms "partially inhibit" and "do not completely inhibit" are opera- 
tionally synonymous but are used for semantic emphasis. 
The data used to define  the presence or absence of each specificity in each 
type strain is given below. The numerical designations of the various antigenic 
determinants are completely arbitrary. 
i  C3H*-C57BL anti-C3H precipitation is not completely inhibited by DBA 
(CR 21).  C3H therefore has at least one specificity not present in DBA 
(C3H 1; C57BL --1; DBA --1). 
ii  DBA*-C57BL anti-C3H precipitation is completely inhibited by AKR. 
Therefore C3H, DBA, and AKR share at least one specificity,  2 (C3H 2; 
C57BL --2; DBA 2; AKR 2). 
iii  AKR*-C57BL  anti-C3H  precipitation  is  partially  inhibited  by DBA 
(CR 10). Therefore AKR and  C3H must share at least one  specificity 
that is not present in DBA (AKR 1). 
iv  C3H*-C57BL  anti-C3H  precipitation  is  not  completely  inhibited  by 
AKR (CR 81).  C3H therefore has at least one specificity not present in 
AKR (C3H 6; C57BL --6; AKR --6). 
v  Since C57BL anfi-C3H recognizes specificity 6, statement ii proves that 
DBA does not have 6, (DBA --6). 
vi  DBA*-C57BL anti-DBA  precipitation  is  not  completely inhibited  by 
C3H or AKR (CR respectively 81, 66). Therefore DBA has at least one 
specificity not present in either of these two strains,  (C3H --3; C57BL 
--3; DBA 3; AKR --3). 
vii  C3H anti-C57BL precipitates C57BL*, but not C3H*, DBA*, AKR*, or 
A/J*.  C57BL therefore has  at least one specificity not present  in  the 
latter four strains,  (C3H --4; C57BL 4; DBA --4; AKR --4; A/J -4). 
viii  C3H*--C57BL  anti-C3H  precipitation  is  completely inhibited  by A/J. 
Therefore A/J has all  specificities  previously assigned  to C3H,  (A/J 1, 
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ix  DBA*-C57BL  anti-C3H  precipitation  is  completely  inhibited  by  CE. 
Therefore CE has specificity 2, (CE 2). 
x  CE anti-129 precipitates  C57BL*. Therefore  C3H and  C57BL share  at 
least one specificity not previously described,  (C3H 7; C57BL 7, CE-7). 
xi  C3H*-CE anti-129 precipitation  is completely inhibited by A/J. There- 
fore A/J must have 7, (A/J 7). 
xii  C57BL*-CE  anti-129  precipitation  is  completely  inhibited  by  DBA 
and AKR. DBA and AKR must also have specificity 7, (DBA 7; AKR 7). 
xiii  AKR*-C57BL  anti-C3H  precipitation  is  completely  inhibited  by  CE. 
Therefore CE has 1, (CE 1). 
xiv  BALB/C  anti-NZB  precipitates  AKR*  and  A/J*.  Therefore  these  2 
strains  must  have  one specificity not  previously recognized.  This  pre- 
cipitation  is not  inhibited  by CE  or C3H.  (AKR  5;  A/J  5;  C3H--5; 
Ce-5.) 
xv  A/J*-C57BL anti-C3H precipitation is not  completely inhibited by CE 
(CR 56). CE therefore does not have 6, (CE --6). 
xvi  DBA*-C57BL anti-DBA precipitation  is completely inhibited  by RIII. 
Therefore RIII has specificities 2 and 3, (RIII 2, 3). 
xvii  AKR*-C57BL  anti-C3H  precipitation  is  partially  inhibited  by  RIII 
(CR 41). RIII therefore does not have 1, (RIII -- 1). 
xviii  C3H*-CE  anti-129  precipitation  is  not  inhibited  by  RIII.  Therefore 
RIII does not have 6 or 7, (RIII --6, --7). 
xix  DBA*-C57BL  anti-DBA  precipitation  is  not  completely  inhibited  by 
CE or A/J  (CR respectively 67, 80). Therefore these latter  two strains 
do not have specificity 3, (A/J -3;  CE --3). 
xx  C57BL*-C3H anti-C57BL precipitation  is not inhibited by CE or RIII. 
Neither of these strains therefore has 4, (CE--4; RIII --4). 
xxi  A/J*-BALB/C anti-NZB precipitation is not inhibited by C57t~L,  RIII 
or DBA. Therefore these three strains do not have specificity 5, (C57BL 
-- 5; DBA -- 5; RIII -- 5). 
xxii  AKR*-C57BL anti-C3H  precipitation  is completely inhibited  by SEA. 
Therefore SEA has 1, (SEA 1). 
xxiii  DBA*-C57BL auti-C3H precipitation  is completely inhibited  by SEA. 
Therefore SEA has 2,  (SEA 2). 
xxiv  C3H*-CE anti-129 precipitation is completely inhibited  by SEA.  There- 
fore SEA has specificities 6 and 7, (SEA 6 and 7). 
xxv  C3H*-C57BL  anti-C3H  precipitation  is  not  completely  inhibited  by 
SEA, (CR 87). Since SEA has so far been assigned all the C3H specifici- 
ties,  a  new specificity must  be given  to  C3H,  which  is not present  in 
C57BL or in SEA, (C3H 8; C57BL --8; SEA --8). 
xxvi  All  strains  previously  shown  to  completely  inhibit  in  C3H*-C57BL 
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xxvii  Since SEA behaves exactly like CE in sections xiv, xix, and xx, SEA does 
not have specificities 3, 4, or 5, (SEA --3, --4, -5). 
The  definition  of  each  antigenic  specificity has  been  made  with  a  single 
given antiserum,  a total of five antisera being used to define the eight specifici- 
ties. Other isoantisera have also been produced whose reactions are consistent 
with the specificities already defined. However in the reactions with these an- 
tisera listed below, it is also possible that they are reacting with other undefined 
specificities whose distributions are identical with one of the previously defined 
eight specificities. 
(a)  C57BL  anti-AKR  and  C37BL  anti-A/J  both  precipitate  all  labeled 
antigens in Table VI except C37BL. This is consistent with both andsera hav- 
ing antibodies to specificity two and with all these strains having this specificity, 
although other antibodies are also probably present. 
(b)  Rill  anti-129 precipitates  C3H*, AKR*,  and A/J*,  but does not pre- 
cipitate  C57BL* or DBA*. This serum therefore does not have antibodies to 
specificity 7, but could have antibodies to specificities 1 and 6. 
(c) C3II*-RIII anti-129 precipitation is completely inhibited by C3H, AKR, 
A/J, CE, and SEA. Since all these test sera contain specificity 1, but only some 
contain 6, the antiserum Rill anti-129 does not contain antibodies to specificity 
6, but has antibodies to specificity 1, or a new specificity whose distribution is 
identical with 1. 
(d)  In many inhibition  assays, test sera were found that partially inhibited 
precipitation  to different degrees.  Comparisons of CR values in a  given assay 
have not been used in the derivation of specificities, although they are consist- 
ent with the data  (see Discussion). One example  of this  type of finding is  as 
follows: C3H*-CSTBL anti-C3H precipitation  is partially  inhibited  by AK_R 
and DBA  (CR respectively 81 and 21). This would be consistent with Table 
VIII, since AKR has at least one more specificity in common with C3H than 
DBA/2 (see Discussion). 
Allelic  Types  of Inbred  Mouse  Strains.--Sixty-eight  mouse  strains  have 
been tested with  several antisera  both by agar  precipitation  and  the  inhibi- 
tion assay. All the strains  could be grouped into classes corresponding  to the 
eight type strains in Table VIII. The results are given in Table X. 
Linkage of Ig-l.--Ig-1  has been found not to be closely linked to the following 
gene loci  (a minimum  of 50 segregating  offspring being tested): Agouti  (A), 
brown (b), albino (c),  dilute short ear (d se), hemolytic complement (hrc),  his- 
tocompatibility-2  (//-2), pinkeye-dilution (p), piebald (s), the X  or Y chromo- 
some, caracul (Ca), and steel (sl). 
DISCUSSION 
The Ig-1  locus,  controlling  isoantigeus  on  mouse  7S T2~-immunoglobulins, 
is highly polymorphlc with eight alleles recognized. Each antigen serologieally ~-~  o0  ~  ~.~ 
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cross-reacts  with  the  others  and  thus shows  multiple antigenic specificities. 
These  are  inherited as  a  single unit and  therefore constitute a  phenogroup 
(23). The present data identifies a minimum of eight such antigenic specificities. 
In the course of this work, a  very sensitive method for  detecting  7S  "r~- 
globulins of a specific isoantigenic type was developed. 
Before discussing the genetics of the antigens, several points on the produc- 
tion  of  the  isoantibodies and  the  precipitation  of  labeled  antigens warrant 
further discussion. An antigen which was itself an antibody directed to some 
protein or tissue component in the host was much more immunogenic than 
gamma globulin from normal sera in all cases where a  direct comparison was 
made. Several workers have specifically studied the immunogenicity of antigen- 
antibody complexes and found them to be far more effective as antigens than 
the antigen alone (24,  25).  It is quite probable that a  similar phenomenon is 
occurring here, the complex being formed in the recipient animal. 
Several points indicate that the antibodies produced are highly avid. The 
precipitation of a  trace-labeled antigen is as complete at approximately 0.01 
#g antigen per tube (or 0.1 #g/ml) as at the concentrations, 100 or more times 
greater, commonly employed in precipitation assays. A single precipitation of 
the labeled mouse "r-globulin without cold antigen is maximal. In  contrast, 
some  rabbit  isoantisera  require  two  or  more  sequential  precipitations  with 
carrier unlabeled antigen to reach maximal precipitation (26). 
The various conditions of precipitation described in Materials and Methods 
(time and temperature of incubation, force of centrifugation, etc.),  have all 
been tested and found to be sufficient for maximal precipitation. The use of 
S-dil  and 3  per  cent BSA as diluents probably serves  two purposes:  (a)  to 
provide a high protein concentration to reduce adsorption of the small amounts 
of antigens to the glass surfaces and (b)  some component of rabbit serum is 
advantageous in obtaining maximal precipitation. 
The  precipitation  of  trace-labeled  preparations  of  "r-globulin  by  specific 
isoantisera was never greater than 75 per cent. Immunoelectrophoresis of the 
labeled antigens with polyvalent rabbit  antisera showed the preparations to 
contain a single "r-globulin arc, although occasionally a line which may be due 
to "rX (27)  is also present. The lack of contamination with t-globulins is con- 
firmed by the failure of specific  anti-fi~A and anti-Hc  1 (a ~-globulin Hc  1 com- 
ponent)  sera  to  precipitate  any significant amount  of label.  However,  the 
preparations do contain 7S 71 as well as 7S  72 (Table  I). The slightly higher 
precipitation by rabbit anti-mouse 7S 72 than by the specific isoantisera is pre- 
sumably due to the content of 7S 7~b as well as 7S 7~a. The differences between 
the various preparations in the amounts precipitated by isoantisera could there- 
fore represent different proportions of 7z-subclasses a and b. Since the precipita- 
tion by polyvalent rabbit antisera did not reach the level of trichloroacetic acid 
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denaturation of protein and/or that there is some protein not recognized by the 
antisera. 
Antigenic specificities  for a  given antigen are  assigned with data derived 
from the precipitation of labeled antigens and inhibition assays. The inhibition 
of precipitation of an I1~-labeled  antigen by unlabeled antigens is a  sensitive 
and powerful method of detecting cross-reactions (CR). In the order of 0.01 
/~g of labeled antigen was used in this work with at least  100  times as much 
of the test or inhibiting antigen. This latter need not be purified but can be 
added in the form of whole serum. The inhibition of precipitation is due to 
competition between the labeled and unlabeled antigens for antibody. However, 
as only that fraction of the antibody population which combines with both 
antigens is competed for, cross-reactions and identities can be distinguished. 
The principle is analogous to that involved in absorption of an antiserum by an 
antigen and then using the absorbed antiserum to react with a second antigen 
(14--16, 23). If a particular antigen present in excess partially (not completely) 
inhibits the precipitation of a labeled antigen by an antiserum, this indicates 
that (a) the antiserum must contain antibodies to n antigenic specificities in the 
labeled antigen, where n  ~_ 2, and (b) the test antigen contains from 1 to n -- 1 
of these specificities. 
In this work a  given antigenic specificity has always been defined with a 
single  antiserum. The  assignment of  a  numbered  specificity to  two  strains 
means that they do share at least one specificity. Further analysis with other 
strains may show that a  specificity can be divided into two or more. Table 
VIII gives the  minimum number  of spectficities  compatible  with the  data. 
Although only one antiserum has been used to define a given antigenic speci- 
ficity, antisera produced in other strain combinations have been shown to have 
patterns of reactions consistent with the definition of that specificity. While 
positive results of this type are consistent with the assigned specificities,  these 
antisera may be reacting to a second specificity which is coincident in its dis- 
tibution among the  tested strains.  Such a  cryptic specificity could only be 
revealed if a strain could be found in which it is absent. 
Comparisons of degrees of partial inhibition (CR values between 0 and 100) 
have not been used in the definition of any of the antigenic specificities.  How- 
ever there are many cases  where the assignment of specificities  is supported 
by this type of data. There are two possible interpretations of differing inter- 
mediate CR values. For example, if two test sera A  and B  gave CR values 
respectively of 70 and 30 in a given inhibition assay, it could indicate that: (a) 
the antiserum reacts with at least three antigenic specificities  in the labeled 
antigen, and that test serum A has two of these three, while test serum B has 
only one of the three; or, (b) the antiserum may only recognize two specificities 
in the labeled antigen, but the serum titers of the two antibodies are markedly 
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residual amount of total antibody to the labeled antigen would be different, 
and would therefore precipitate different amounts. In some cases, we can infer 
that the antibody titers are similar and hence, the former explanation can be 
used as supportive evidence. 
Further expansion of the table of specificities will depend upon the produc- 
tion of new isoantisera. The most satisfactory combinations would be ones in 
which according to Table VIII,  only a  unispecific antiserum should be pro- 
duced. An example of this would be to immunize RIII with DBA/2 serum in 
an attempt to produce an antiserum that would only react with specificity 7. 
If the precipitation of labeled antigen of the immunizing strain by such an 
antiserum could be partially, but not completely, inhibited by any test serum, 
it could only mean that the antiserum was reacting to more than one antigenic 
specificity; ~.e., was not unispecific. This would then define a new specificity. 
By this means, the specificities assigned to a given allele would be confirmed or 
more would be added. Similar tests with all strains currently grouped with the 
same type strains would be necessary in order to detect any new alleles. If a 
strain were found to be different from its respective type strain, it would be- 
come a new type strain for a new allele. 
Each  individual  antigenic specificity, designated by  a  number,  indicates 
that all antigens having this number have structural features which allow them 
to react  with a  common fraction of the antibody population. The  chemical 
nature of the antigenic specificities  is however at present ~ml~nown. Although 
it is not formally ruled out that these antigens are carbohydrate, it is likely 
that they result from protein structural differences, in view of the large number 
of cross-reactions observed. 
The relationship between the defined antigenic specificities  and the structure 
of the whole antigen has not been completely understood in any cross-reacting 
antigen system. Individual specificities  may represent single haptenic groups or 
combinations of them, and cross-reactions would be a reflection of the distribu- 
tion of the haptenic groups among different antigens. Or, as proposed by Owen; 
"The symbols (specificities)  actually stand for fractions of antibody in a hetero- 
geneous  molecular population"  (28).  In  this  case,  antibody molecules  in  a 
given antiserum are  all produced in response  to  a  single antigen and  have 
varying affinities for related antigens. Thus, the related antigen could absorb 
some, but not all, of the antibody molecules in the antiserum. These two ex- 
planations are not mutually exclusive and are both formally consistent with 
the serological  analysis carried out in this paper. 
The relationship between the  antigenic analysis and  the structure  of the 
antigens depends  on whether  the antigenic specificities are  all on the  same 
molecules or on separate molecules. The data in Table VII indicates that some 
of the shared specificities are on the same molecules. The tendency to reach 
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with all antisera reacting with the preparation,  supports this interpretation. 
However, in view of the great heterogeneity of gamma globulins  (29),  these 
results  are  also  consistent with a  statistical sharing of specificities.  That is, 
there may be many subpopulations of molecules each sharing some but not all 
"subspecificities" 1, U, 1", 1  m . .., 2, T, 2", 2  m ... present in that strain so 
that all the molecules would be precipitated by any antiserum with anti 1 and 
anti 2 activity as defined above.  Subspecificities  may be thought of as slight 
differences in association constants between antigen and antibody molecules. 
The conclusion that each of the eight antigens are  controlled by alleles at 
one locus is based upon genetic and molecular evidence. The first four antigens 
identified Ig-la through Ig-ld were shown to be controlled by alleles by direct 
genetic test. That the remaining four Ig-1  antigens are  controlled by alleles 
at the same locus requires a statement of the meaning of the term "locus" in a 
mammal. "Locus" in higher organisms has come to be synonymous with "cis- 
tron"  in  microbial  genetic  terminology, that  is,  the  region  of  chromosome 
coding for the structure of a polypeptide chain. The original definition of locus 
as a region not separable by crossing over has been neglected whenever it be- 
came inconsistent with the newer structural definition (30, 31).  Thus, for our 
purposes here, the association of the various Ig-1 antigens with a  single poly- 
peptide would be the most cogent evidence for terming Ig-1 a locus. It has been 
shown that some, if not all, of the Ig-1 antigenic specificities  are on the same 
class of protein molecules. Furthermore, it has previously been demonstrated 
that they are associated with only one constituent polypeptide chain of these 
molecules (11). Thus, except for the reservations concerning some of the anti- 
genic specificities, we conclude that the  eight antigens are  all  controlled by 
alleles at the Ig-1 locus. 
The evolutionary mechanism of development of a complex multiallelic locus 
such as Ig-1 may have been based on crossovers within the locus giving new 
combinations of antigenic specificities.  Although no evidence of crossing-over 
in approximately 150 mice tested has been obtained, this number of animals 
still allows for a maximum crossover distance between specificities  of approxi- 
mately 2.5 per cent, which is considerably greater than the known value for the 
interlocus  distance  for  the  genes  dilute  and  short  ear  (32).  This  proposed 
mechanism is similar to observations in the H-2 system where new alleles have 
been actually known to arise by crossing-over (15).  Different specificities  may 
also have arisen by mutation. 
Of all the strains so far examined in detail, only one of the alleles (Ig-1 b) de- 
termines an antigenic specificity (No. 4) that is not present in any other antigen. 
Gamma globulin of this type would therefore be antigenic for a recipient strain 
of any other allele. The other gamma globulins differ by virtue of the combina- 
tions  of  antigenic  specificities  composing  the  antigen. 
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assistance in tracing the lineage of that strain. Several examples are known of 
strains of a common origin  showing  the common specificities  (CE, DE; SEA, 
SEC; the C57BL strains; and the NZ strains). 
A  notation  for mouse immunoglobulin  loci  and  their  phenotypes has  not 
been generally adopted and several notations have been published  (5-8,  10, 
11). It would obviously be desirable to find one  which is generally acceptable. 
The revised nomenclature recently proposed for the  Rh  blood group' system 
in man and the histocompatibility genes and antigens in the mouse (16, 33), 
provides a model for the notation used in this paper (13). In view of the cross- 
reactions between the strains so far studied, the designation of a  type strain 
for each allele is advantageous. 
The antigens recognized by an antiserum in one laboratory may be presumed 
to be identical with those in another laboratory if sufficient evidence exists of 
consistency of reactions of the antiserum with a large number of inbred strains. 
It is likely, that the antigens 7sA(5), Asa1(34), and MuM (7) refer to the same 
allele  designated  in  this  paper  as  Ig-la;  MuA2  (7),  Asa  ~ (34)  probably are 
equivalent to Ig-lb; Asa  3 (34) to Ig-lc; Asa  4 (34) to Ig-la;and AsaS(34) to Ig-U. 
The notations Gg and Iga previously used in this laboratory are replaced by 
Ig-1 system. 
The  usefulness  of  the  immunoglobulin  isoantigens  as  markers  in  many 
systems is  readily apparent.  Donor type antibody production  in rabbits  by 
transferred  donor lymphoid cells  (35),  and  donor type gamma globulin syn- 
thesis in mouse radiation chimeras (36, 37) exemplify their application in cell 
transfer  systems.  Further  use as markers  has  been made  in  studies  on  the 
structure (38-42) and timing of synthesis of gamma globulins (43). 
A  second irnmunoglobulin  locus,  Ig-2,  controlling  antigens  on  mouse  71A 
(t~zA)-globulin has been found which is closely linked  to  Ig-1  (10).  Further 
investigation is in progress to detect loci controlling  isoantigens  on the other 
subclasses of rnurine  immunoglobulins. 
SDM'taARy 
Eight antigens of 7S  7~-immunoglobulins  controlled  by alleles at  a  single 
locus Ig-1, have been identified  in mice. -This locus has previously been shown to 
determine antigenic specificities on the  F  fragments of 7S 72a-globulins. The 
reactions of these antigens with various isoantisera have shown that the anti- 
gens all cross react with one another. 
New methods for the analysis of antigenic specificities of soluble proteins are 
presented in detail. A sensitive method for detecting in the order of 0.01 gg of 
these isoantigens  has been developed, based on the quantitative inhibition of 
precipitation of l~*S-labeled antigen. 
Cross-reactions  of the antigens were analysed in inhibition  assays and  the 
data is compatible with the existence of a minimum of eight antigenic specifici- 436  MOUSE IM'~UNOGLOBULIN ISOANTIGENS. I 
ties. Each of the antigens is composed of different combinations of these specifi- 
cities, with only one antigen having a specificity not present in any other. 
Sixty-eight mouse strains have been tested with  specific isoantisera,  and  on 
the basis of the results, have been placed into the eight allele groups. 
Evidence for close genetic linkage of the Ig-1 locus and 11  chromosome mark- 
ers has been sought and not found. 
Sera and/or mice were kindly sent by Dr. B. Amos, Dr. M. Bielschowsky, Dr. J. Fahey, 
Dr. M. Green, Dr. E. Jensen, Dr. H. S. Mieklem, Dr. R. I. Mishell,  Dr. L. Norins,  Dr. L. 
Old, Dr. L. B. Russell, and Dr. D. Shreffter. The authors are grateful for assistance  in the 
preparation of iodinated antigens to R. Griepp, R. Lanzerotti, and J. Minna, to Dr. R. Wistar 
for critical  review of the manuscript, and for excellent technical  assistance  to Miss J. Tripp 
and M. Iverson. 
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Addendum.--Mter  submission  of this  report,  the article by R.  Lieberman and  S. 
Dray (Five allelic genes of the Asa locus which control ~/-globulin  allotypic specificities 
in mice, J. Immunol.,  1964,  93,  584)  referred to in the text as reference 34 was pub- 
lished.  Several of their allele groups have here been subdivided.  Ig-1  a and  Ig-1  h are 
in  the Asa  ~ group, and If-1  ¢ and Ig-a* are in the Asa  8 group. 
The  system  of  defining  antigenic  components  (specificities)  used  by  Lieberman 
and Dray does not meet the necessary criteria for assigning the minimum number of 
specificities compatible with observed cross reactions. For example, different antigens 
may  differ  because  they  have  different  combinations  of  specificities.  Each  antigen 
need  not have a  unique  specificity. Thus,  no  direct  comparison is possible between 
our Table VIII and their specificity assignments. 